RecruitingPhase 3NCT07207811
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Studying Amyloidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Novo Nordisk A/S
- Principal Investigator
- Clinical Transparency (dept. 2834)Novo Nordisk A/S
- Intervention
- NNC6019-0001(drug)
- Enrollment
- 1280 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2029
Study locations (30)
- Mayo Clinic Hospital, Phoenix, Arizona, United States
- University of California San Diego (UCSD) - Sulpizio Cardiovascular Center (SCVC), La Jolla, California, United States
- Keck School of Medicine USC - Healthcare Consultation Center 2 (HCCII), Los Angeles, California, United States
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, United States
- UCI Medical Center, Orange, California, United States
- Profound Research LLC at Southern California Heart Specialists, Pasadena, California, United States
- University of California, San Francisco Medical Center, San Francisco, California, United States
- Northbay Cardiology Inc., Santa Rosa, California, United States
- Lucile Packard Children's Hospital, Stanford, California, United States
- Yale University School of Medicine, New Haven, Connecticut, United States
- MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
- UF Health Heart and Vascular Hospital, Gainesville, Florida, United States
- Northeast Georgia Heart Center, Pc (Nghc), Gainesville, Georgia, United States
- The Queen's Medical Center, Honolulu, Hawaii, United States
- Northwestern University Clinical and Translational Sciences Institute, Chicago, Illinois, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07207811 on ClinicalTrials.govOther trials for Amyloidosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07560306[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid CardiomyopathyBrigham and Women's Hospital
- RECRUITINGNCT07494656A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in GermanyPfizer
- RECRUITINGPHASE2NCT07285044The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasMayo Clinic
- RECRUITINGNCT07218705A Study Of MCG In Cardiac AmyloidosisMayo Clinic
- ENROLLING BY INVITATIONPHASE2NCT06723015Tau PET Outcomes With Anti-amyloid ImmunotherapiesMayo Clinic
- RECRUITINGNCT07213297Comprehensive Program for Hereditary Transthyretin AmyloidosisHospital de Alta Complejidad en Red
- RECRUITINGPHASE1NCT06790394Test-retest Study With [18F]FBB in Cardiac AmyloidosisLife Molecular Imaging GmbH
- RECRUITINGNANCT07112066Multimodality Cardiac Imaging for Disease Progression in ATTR-CMDominik Benz